HIGHLIGHTS
- who: Elena Ruxandra Radu et al. from the Department of Analytical Chemistry and Environmental Engineering, University Politehnica of Bucharest have published the research work: Recent Advances in Stimuli-Responsive Doxorubicin Delivery Systems for Liver Cancer Therapy, in the Journal: Polymers 2022, 14, 5249 These of /2022/
- what: The aim of this dualu2011responsive drug delivery was to create a special delivery of DOX in the presence of glutathione (GSH) and acidic pH in the tumor microenvironment.
- how: The same results were shown in the case of hydrophobic paclitaxel (PTX) which is a hydrophobic anticancer . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.